tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Novartis downgraded to Neutral from Outperform at Oddo BHF

Oddo BHF downgraded Novartis to Neutral from Outperform. The analyst sees limited valuation upside and clinical news flow in the near-term.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on NVS:

Disclaimer & DisclosureReport an Issue

1